Nonalcoholic fatty liver disease and cardiovascular risk in children with obesity

Obesity

Volumn 23, Issue 6, 2015, Pages 1239-1243

  Koot, Bart G P ^a   De Groot, Eric ^b,c   Van Der Baan Slootweg, Olga H ^d   Bohte, Anneloes E ^b   Nederveen, Aart J ^b   Jansen, Peter L M ^b   Stoker, Jaap ^b   Benninga, Marc A ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Matrix II   (Netherlands)

^d Childhood Obesity Centre Heideheuvel   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROGENESIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; DISEASE SEVERITY; FATTY LIVER; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PROTON NUCLEAR MAGNETIC RESONANCE; RISK FACTOR; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHILDHOOD OBESITY; COMPLICATION; PATHOLOGY;

ADOLESCENT; ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHILD; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PEDIATRIC OBESITY; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84929950383     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21076     Document Type: Article

References (29)

1. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE,. Advances in pediatric nonalcoholic fatty liver disease. Hepatology 2009; 50: 1282-1293.
2. Ekstedt M, Franzen LE, Mathiesen UL, et al., Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006; 44: 865-873.
3. Schindhelm RK, Diamant M, Heine RJ,. Nonalcoholic fatty liver disease and cardiovascular disease risk. Curr Diab Rep 2007; 7: 181-187.
4. Sookoian S, Pirola CJ,. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008; 49: 600-607.
5. Targher G, Day CP, Bonora E,. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-1350.
6. Kozakova M, Palombo C, Eng MP, et al., Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology 2012; 55: 1406-1415.
7. Stepanova M, Younossi ZM,. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol 2012; 10: 646-650.
8. Targher G, Bertolini L, Padovani R, et al., Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29: 1325-1330.
9. Pacifico L, Cantisani V, Ricci P, et al., Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008; 63: 423-427.
10. Demircioglu F, Kocyigit A, Arslan N, Cakmakci H, Hizli S, Sedat AT,. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2008; 47: 68-75.
11. Caserta CA, Pendino GM, Alicante S, et al., Body mass index, cardiovascular risk factors, and carotid intima-media thickness in a pediatric population in southern Italy. J Pediatr Gastroenterol Nutr 2010; 51: 216-220.
12. Pacifico L, Anania C, Martino F, et al., Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology 2010; 52: 1643-1651.
13. Kelishadi R, Cook SR, Amra B, Adibi A,. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. Atherosclerosis 2009; 204: 538-543.
14. Weghuber D, Roden M, Franz C, et al., Vascular function in obese children with non-alcoholic fatty liver disease. Int J Pediatr Obes 2011; 6: 120-127.
15. Manco M, Bedogni G, Monti L, Morino G, Natali G, Nobili V,. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease. Atherosclerosis 2010; 209: 463-468.
16. Alp H, Karaarslan S, Selver EB, Atabek ME, Altin H, Baysal T,. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. Can J Cardiol 2013; 29: 1118-1125.
17. Huang RC, Beilin LJ, Ayonrinde O, et al., Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology 2013; 58: 1306-1314.
18. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH,. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
19. Tanner JM,. Growth and endocrinology of the adolescent. In:, Gardner L, (ed). Endocrine and Genetic Diseases of Childhood. Philadelphia: WB Saunders; 2014.
20. Klijn PH, van der Baan-Slootweg OH, van Stel HF,. Aerobic exercise in adolescents with obesity: preliminary evaluation of a modular training program and the modified shuttle test. BMC Pediatr 2007; 7: 19.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
22. van Werven JR, Marsman HA, Nederveen AJ, et al., Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 2010; 256: 159-168.
23. Bohte AE, Koot BG, van der Baan-Slootweg OH, et al., US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents. Radiology 2012; 262: 327-334.
24. de Groot E, Hovingh GK, Wiegman A, et al., Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004; 109 (Suppl 1): III33-III38.
25. Groothoff JW, Gruppen MP, Offringa M, et al., Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 2002; 13: 2953-2961.
26. Lamotte C, Iliescu C, Beghin L, et al., Association of socioeconomic status, truncal fat and sICAM-1 with carotid intima-media thickness in adolescents: the HELENA study. Atherosclerosis 2013; 228: 460-465.
27. Bohte AE, Koot BG, van der Baan-Slootweg OH, et al., US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents. Radiology 2012; 262: 327-334.
28. Gokce S, Atbinici Z, Aycan Z, Cinar HG, Zorlu P,. The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children. Pediatr Cardiol 2013; 34: 308-315.
29. Sanyal AJ, Brunt EM, Kleiner DE, et al., Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 2011; 54: 344-353.